Duality Advisers, LP Jazz Pharmaceuticals PLC Transaction History

Duality Advisers, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$115.19 - $132.77 $579,751 - $668,231	-5,033 Reduced 19.63%	20,608 $2.48 Million
Q4 2023 Feb 01, 2024	BUY	$114.26 - $136.0 $772,169 - $919,088	6,758 Added 35.79%	25,641 $3.15 Million
Q3 2023 Nov 02, 2023	BUY	$122.0 - $145.31 $47,336 - $56,380	388 Added 2.1%	18,883 $2.44 Million
Q2 2023 Jul 31, 2023	BUY	$122.5 - $147.16 $2.27 Million - $2.72 Million	18,495 New	18,495 $2.29 Million
Q3 2022 Nov 03, 2022	BUY	$126.59 - $161.18 $2.62 Million - $3.33 Million	20,672 New	20,672 $2.76 Million
Q1 2022 May 09, 2022	SELL	$129.64 - $160.7 $456,851 - $566,306	-3,524 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$119.87 - $145.67 $422,421 - $513,341	3,524 New	3,524 $449,000
Q3 2021 Nov 08, 2021	SELL	$128.64 - $184.79 $376,915 - $541,434	-2,930 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$160.2 - $186.42 $956,073 - $1.11 Million	-5,968 Reduced 67.07%	2,930 $520,000
Q1 2021 May 13, 2021	BUY	$150.19 - $173.5 $912,704 - $1.05 Million	6,077 Added 215.42%	8,898 $1.46 Million
Q4 2020 Feb 09, 2021	BUY	$140.71 - $165.05 $396,942 - $465,606	2,821 New	2,821 $466,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.